SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wright Leigh Alexander

(Last) (First) (Middle)
7140 OFFICE CIRCLE

(Street)
EVANSVILLE IN 47715

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/04/2007
3. Issuer Name and Ticker or Trading Symbol
ACCURIDE CORP [ ACW ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SR. VP/Accuride Wheels
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
common stock 1,605 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
stock option (right to buy) (1) 03/08/2014 common stock 5,319 $2.962 D
stock option (right to buy) (2) 05/05/2016 common stock 14,000 $10.98 D
Stock Appreciation Right (3) 12/19/2016 common stock 11,034 $11.34 D
Restricted Stock Units (4) (4) common stock 2,982 (4) D
Stock Appreciation Right (5) 06/14/2017 common stock 7,566 $15.14 D
Restricted Stock Units (6) (6) common stock 2,958 (6) D
Explanation of Responses:
1. 2,659 shares are exercisable. 2,660 shares vest on December 31, 2007.
2. 3,500 shares are vested and exercisable. The 10,500 remaining shares vest in three equal installments of 3,500 shares on 12/31/07, 12/31/08 and 12/31/09, respectively.
3. 100% of the shares subject to Stock Appreciation Right (the "SAR") will fully vest and become exercisable on December 31, 2009. Notwithstanding the foregoing, if certain future performance goals are met annually, 25% of the total number of shares subject to the SAR will fully vest and become exercisable on December 31, 2007 and December 31, 2008, respectively.
4. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Accuride stock. 1,278 of the RSUs will vest on December 1, 2008 and the remaining 1,704 RSUs will vest on December 1, 2009.
5. 100% of the shares subject to Stock Appreciation Right (the "SAR") will fully vest and become exercisable on December 31, 2010. Notwithstanding the foregoing, if certain future performance goals are met annually, 25% of the total number of shares subject to the SAR will fully vest and become exercisable on December 31, 2007, December 31, 2008, and December 31, 2009, respectively.
6. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Accuride stock. 657 of the RSU's will vest on December 1, 2008, 986 will vest on December 1, 2009 and the remaining 1,315 of the RSUs will vest on December 1, 2010.
/s/ Leigh Wright 12/12/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.